Prescription medicine
Tetrofosmin Brand names: Myoview
Tetrofosmin (Myoview) is a prescription medicine. No generic is listed in FDA's NDC Directory.
- No generic listed
Check it at the source: the tetrofosmin FDA label on DailyMed (effective January 10, 2024); every tetrofosmin label on DailyMed.
Highlights of the record
FDA label of January 10, 2024; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageMYOVIEW 30 mL is a kit for the preparation of technetium Tc99m tetrofosmin for injection.
Forms and strengths
- 0.23 mg
- 1.38 mg
Injection (powder) (lyophilized) for solution.
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 1 of which 0 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 692 through July 30, 2026
What is tetrofosmin used for?
From the label: indications and usageMYOVIEW 30 mL is a kit for the preparation of technetium Tc99m tetrofosmin for injection. […]
Source: FDA drug label (Myoview), Medi-Physics Inc. dba GE Healthcare, effective January 10, 2024 (SPL set 98c85037-a907-4a3a-8864-c3a5298b4759), via openFDA; the full label on DailyMed
Is there a generic for tetrofosmin (Myoview)?
No generic tetrofosmin is approved (Drugs@FDA, October 8, 2026).
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What does the tetrofosmin label say about other medicines?
The tetrofosmin label names 1 other medicine in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Tetrakis copper tetrafluoroborate | warnings and precautions | Radiation Risks Technetium Tc99m contributes to a patient's overall long-term cumulative radiation exposure. |
Source: FDA drug label (Myoview), Medi-Physics Inc. dba GE Healthcare, effective January 10, 2024 (SPL set 98c85037-a907-4a3a-8864-c3a5298b4759), via openFDA; the full label on DailyMed
What do FAERS reports show for tetrofosmin?
The FDA Adverse Event Reporting System holds 692 reports that list tetrofosmin among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 5 are coded as a death and 55 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Tetrofosmin side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other